Table: begin end state 1 29 cytoplasmic 30 34 non-cytoplasmic 35 51 transmembrane 52 56 non-cytoplasmic 57 80 transmembrane 81 92 cytoplasmic 93 111 transmembrane 112 117 non-cytoplasmic 118 145 transmembrane 146 157 cytoplasmic 158 180 transmembrane 181 191 non-cytoplasmic 192 211 transmembrane 212 244 cytoplasmic 245 263 transmembrane 264 280 non-cytoplasmic 281 300 transmembrane 301 311 cytoplasmic 312 331 transmembrane 332 336 non-cytoplasmic 337 355 transmembrane 356 375 cytoplasmic 376 397 transmembrane 398 402 non-cytoplasmic 403 424 transmembrane 425 456 cytoplasmic
Input: >WP_007735697.1 NCBI__GCF_002893965.1:WP_007735697.1 MNDANPPSPATVDRPALRRVAGSVLVGTTIEWYDFQIYGASAALVFAPLFFSGADPALAT ILSFATFAVGFLARPLGGVVMGHFGDRIGRKKVLVLALLLMGAATFLVGVLPTSAQIGVW APILLVLLRLIQGFGVGGEWGGAVLTAVEYAPKNRRGFYGSMPQVGVPAGLLLATAVMFG TKALTGDQFLVWGWRIPFLLSIALVAVGLYIRTALEETPAFARVKQQNTAVKIPMVDAFK NYPRQIILAAGSMISTGAYFYILNTYSLTYADQFDLLSGNLMLGAVMVSALVAVIFIPIF GQLSEKFGRRRILMVGITGMGVWVFVAFAAIDTGNFWITTGALAVGAFMLSISYGPQATF IAELFDARVRYSAASIAFQIGVLLGGAIAPMVAAMLVRATGGSLAVAVYIAALSVISLIS VYFVRDTDLDEGSRDMYIDDNGAYLPPVDQRSTVVN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server